Clinical Trial: Phase 3 Randomized, Modified Double-blind, Active-controlled Safety Study on vYF in Adults

U.S., June 4 -- ClinicalTrials.gov registry received information related to the study (NCT07002060) titled 'Phase 3 Randomized, Modified Double-blind, Active-controlled Safety Study on vYF in Adults' on May 23.

Brief Summary: The purpose of this study is to assess the safety of vYF (investigational vaccine) compared to the safety of YF-VAX (YF licensed vaccine) in adults aged 18 years up to 60 years.

Study details include:

* The study duration will be up to approximately 6 months.

* One single dose of the study intervention (vYF or YF-VAX) will be administered subcutaneously at the 1st visit.

* The visit(V) frequency will be Day(D) 01 (V01) and D29 (V02). Two telephone calls will be planned at D15 and Month(M)6.

Number of Participants...